Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Dropped 53.2% in First Quarter of 2022

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 136.1 million yuan in the first quarter of 2022, down 53.2% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, down 17.4% year-on-year.

At the end of the reporting period, it had 19.5 billion yuan in total assets and 9 billion yuan in total liabilities, with a liability-to-asset ratio of 46.1%.